Beam Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Beam Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 520% to $377,709,000. The net income raised on -$132,526,999 and profit margin reached -35%. Total operating expenses were $554,194,000.
Profit Margin
| 2017 | 0 | -8.00M | |
|---|---|---|---|
| 2018 | 0 | -115.25M | |
| 2019 | 18K | -78.44M | -435788.89% |
| 2020 | 24K | -256.42M | -1068433.33% |
| 2021 | 51.84M | -341.36M | -658.44% |
| 2022 | 60.92M | -263.58M | -432.68% |
| 2023 | 377.70M | -132.52M | -35.09% |
BEAM Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 377.70M | 60.92M | 51.84M | 24K | 18K | 0 | 0 |
Cost of revenue | 437.38M | 22.57M | 16.44M | 103.17M | 5.40M | 0 | 11K |
Gross profit | -59.67M | 38.34M | 35.40M | -103.15M | -5.38M | 0 | -11K |
Operating exp. | |||||||
Research and development | 437.38M | 311.59M | 387.08M | 103.17M | 54.61M | 33.87M | 5.85M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 554.19M | 399.39M | 444.30M | 132.78M | 75.17M | 45.74M | 7.88M |
Operating income | -176.48M | -338.47M | -392.46M | -132.76M | -75.15M | -45.74M | -7.88M |
Other income (expenses), net | 45.32M | 78.30M | 21.82M | -61.83M | -3.17M | -71.28M | -122K |
Income before tax | -131.16M | -260.17M | -370.63M | -194.59M | -78.32M | -116.73M | -8.00M |
Income tax expense | 1.36M | 3.41M | -29.27M | 61.83M | 116K | -70.99M | 500K |
Net income | -132.52M | -263.58M | -341.36M | -256.42M | -78.44M | -115.25M | -8.00M |
Earnings per share | |||||||
Basic EPS | -1.72 | -3.76 | -5.31 | -5.49 | -1.53 | -3.28 | -0.62 |
Diluted EPS | -1.72 | -3.76 | -5.31 | -5.49 | -1.53 | -3.28 | -0.62 |
| Data source | Data source | Data source | Data source | Data source |